heart failure

News

Novo Nordisk microRNA drug fluffs its lines in heart failure

A microRNA-targeting drug acquired by Novo Nordisk when it bought Cardior in a $1bn-plus deal has generated disappointing results in heart failure.

News

One in four diabetics has undiagnosed heart failure; study

A study has found that undiagnosed heart failure can be detected in people with high-risk diabetes using a simple, GP-led care pathway.

News

GSK grows pipeline with 35Pharma takeover, Frontier deal

GSK CEO Luke Miels signs a pair of pipeline-expanding deals, and the first acquisition on his watch, as the group prepares for a looming patent cliff.

News

Abbott's wireless heart failure sensor cleared for NHS use

A wireless sensor the size of a paperclip, Abbott's CardioMEMS HF, can now be used routinely by the NHS to monitor patients with heart failure.

News

ESC: MSD/Bayer's Verquvo disappoints in heart failure trial

Bayer and MSD's hopes of expanding the use of Verquvo in heart failure have been dashed by a failed phase 3 trial.

News

ESC: Study says GLP-1s treat heart failure AND cut emissions

Add a beneficial impact on climate change to the long list of benefits being attributed to GLP-1 agonist medicines.

Novo Nordisk microRNA drug fluffs its lines in heart failure

One in four diabetics has undiagnosed heart failure; study

GSK grows pipeline with 35Pharma takeover, Frontier deal

Abbott's wireless heart failure sensor cleared for NHS use

ESC: MSD/Bayer's Verquvo disappoints in heart failure trial

ESC: Study says GLP-1s treat heart failure AND cut emissions

OpenBind unveils its first AI model for drug discovery

Discover a new era of healthcare panel engagement: Grounded ...

heart failure

Editor's Picks